Ordeniza, Lexie Zane Y.

HRN: 21-35-76  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2022
CEFTRIAXONE 1G (VIAL)
10/18/2022
10/28/2022
IVTT
660mg
Q24
Infectious Gastroenteritis
Waiting Final Action 
10/18/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/18/2022
10/25/2022
IVTT
100mg
Q24h
Sepsis
Waiting Final Action 
10/21/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
10/21/2022
10/28/2022
PO
3ml
Q8
Intestinal Parasitisim
Waiting Final Action 
10/21/2022
MUPIROCIN 2%, 15G (TUBE)
10/21/2022
10/28/2022
TOPICAL
Apply On Affected Area
Q8
IV Puncture Site Wounds
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: